Biologics as a therapeutic approach for a Th17-mediated severe dermatitis in skin barrier disorders

Allergy. 2020 Nov;75(11):3007-3008. doi: 10.1111/all.14475. Epub 2020 Aug 24.

Authors

Carmen Riggioni^{1

2}, Montserrat Alvaro-Lozano^{1

2}, Laia Alsina^{1

2

3

4}

Affiliations

¹ Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
² Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
³ Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona Spain, Barcelona, Spain.
⁴ Universitat de Barcelona, Barcelona, Spain.

PMID: 32583554
DOI: 10.1111/all.14475

No abstract available

Keywords: SAM-like syndrome; T helper 17; biologics; secukinumab.

MeSH terms

Biological Factors
Biological Products*
Dermatitis, Atopic*
Humans
Psoriasis*
Skin
Th17 Cells

Substances

Biological Factors
Biological Products